Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
July 31, 2026 29.61%
April 30, 2026 29.75%
January 31, 2026 26.72%
October 31, 2025 28.13%
July 31, 2025 29.44%
April 30, 2025 31.16%
January 31, 2025 27.36%
October 31, 2024 29.21%
July 31, 2024 25.81%
April 30, 2024 25.82%
January 31, 2024 25.72%
October 31, 2023 26.70%
July 31, 2023 23.90%
April 30, 2023 19.19%
January 31, 2023 16.98%
October 31, 2022 15.95%
July 31, 2022 12.36%
April 30, 2022 18.76%
January 31, 2022 13.84%
October 31, 2021 9.22%
July 31, 2021 14.37%
April 30, 2021 15.66%
January 31, 2021 16.96%
October 31, 2020 16.40%
July 31, 2020 16.15%
Date Value
April 30, 2020 14.27%
January 31, 2020 15.42%
October 31, 2019 15.90%
July 31, 2019 17.66%
April 30, 2019 13.93%
January 31, 2019 16.16%
October 31, 2018 20.56%
July 31, 2018 17.99%
April 30, 2018 20.49%
January 31, 2018 21.99%
October 31, 2017 19.08%
July 31, 2017 20.13%
April 30, 2017 21.20%
January 31, 2017 16.57%
October 31, 2016 19.55%
July 31, 2016 19.15%
April 30, 2016 20.08%
January 31, 2016 16.93%
October 31, 2015 17.82%
July 31, 2015 18.79%
April 30, 2015 17.63%
January 31, 2015 16.06%
October 31, 2014 19.24%
July 31, 2014 20.13%
April 30, 2014 21.63%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Enovis Corp. 54.51%
Edwards Lifesciences Corp. 78.09%
IDEXX Laboratories, Inc. 64.07%
Intuitive Surgical, Inc. 67.76%
Neogen Corp. 37.59%